REXAHN PHARMACEUTICALS, Inc. (AM:RNN)

0.65

+0.01 (1.56%)

REXAHN PHARMACEUTICALS, Inc. (AM:RNN) Delayed :
Previous Close	$0.64	52 Week High	$2.00
Open	$0.63	52 Week Low	$0.40
Day High	$0.67	P/E	N/A
Day Low	$0.63	EPS	$-0.11
Volume	3,700
More RNN Info: Chart SEC Filings Profile Historical Options

What is this?Friends, Peers and Foes

Ticker	# Stories	Ticker	# Stories
TEVA	2	BEST	1
PHC	1	S	1
GSK	1	CIT	1
PTR	1	TWIN	1
HW	1	ARTX	1
CWBC	1	RMTI	1

View All Entities

Oct 19, 2009 10:48 AM Morning Movers 10/19: FIGI, IPCS, BEST, ALLI, CIT Higher; JACO, FNM, IDCC, FRE, PETS Lower
Oct 19, 2009 09:26 AM Rexahn (RNN) Announces Positive Top-Line Results From Phase IIa Study of SerdaxinTM
Sep 17, 2009 09:37 AM Morning Movers 9/17: HYTM, IVAN, XNPT, RNN, BSTC, AMR, SOLF Higher; DARA, SNV, HW Lower
Sep 17, 2009 08:41 AM Rexahn Pharmaceuticals (RNN) and Teva Pharmaceuticals (TEVA) Agree to Close on a License Agreement
Aug 10, 2009 10:56 AM Rexahn Pharma (RNN) Promotes Rick Soni to President and Chief Operating Officer

Nov 17, 2009 08:00AM Rexahn Pharmaceuticals Provides Third Quarter 2009 Business Update
Nov 9, 2009 08:00AM Rexahn's ArchexinTM Recognized as One of Windhover's Top 10 Most Promising Oncology Products
Oct 26, 2009 08:00AM Rexahn Pharmaceuticals Announces Closing of Public Equity Offering
Oct 22, 2009 08:00AM New Animal Study Featured in the Journal of Cellular Biochemistry Supports Rexahn's Archexin(TM) as Potent Inhibitor of Human Cancer Cell Growth
Oct 19, 2009 12:16PM Rexahn To Raise $5 Million in Registered Direct Offering

Nov 16, 2009 04:21PM Form 10-Q REXAHN PHARMACEUTICALS, For: Sep 30
Nov 9, 2009 05:10PM Form NT 10-Q REXAHN PHARMACEUTICALS, For: Sep 30
Oct 26, 2009 06:16AM Form 8-K REXAHN PHARMACEUTICALS, For: Oct 23
Sep 30, 2009 04:19PM Form SC 13D/A REXAHN PHARMACEUTICALS, Filed by: Rexgene Biotech Co., Ltd.

No comments are currently available.